Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Biomedical Advanced Research and Development Authority (BARDA), an agency under the Department of Health and Human Services, has issued a Broad Agency Announcement (BAA). This BAA seeks to advance the development of FloPatch FP120 with FloPredict Alert as a Burn and Blast Medical Countermeasure. The initiative supports BARDA's mission to develop medical countermeasures (MCMs) against CBRN threats, pandemic influenza, and emerging infectious diseases.
Scope of Work
This BAA focuses on clinical and product development activities for the FloPatch FP120 with FloPredict Alert. The scope of work encompasses:
- Clinical Studies: Conducting necessary trials and research.
- Algorithms Development: Creating and refining computational models.
- Hardware and Software Development: Designing and implementing required technologies.
- Associated Activities: Including regulatory, quality assurance, management, and administrative tasks.
The Government has identified a Bona Fide Need for each non-severable discrete work segment. Contractor success will be evaluated based on specified Deliverables and Milestones, which will determine the Government's decision to exercise any follow-on option periods.
Contract & Timeline
- Opportunity Type: Broad Agency Announcement (BAA)
- Agency: BARDA, HHS (Office of Assistant Secretary for Preparedness and Response)
- Product/Service Code: AN13 (Health R&D Services; Health Care Services; Experimental Development)
- Set-Aside: None specified
- Published Date: June 5, 2026
Additional Notes
This BAA operates under the authority of the Pandemic and All Hazards Preparedness Act (PAHPA) of 2006, reauthorized in 2013 and 2019. BARDA is also tasked with fostering innovation in technologies for manufacturing, testing, and utilization of medical countermeasures. For inquiries, contact BARDA-BAA@hhs.gov.